A20-Binding Inhibitor of NF- B (ABIN1) Controls Toll-Like Receptor-Mediated CCAAT/enhancer-binding Protein Activation and Protects From Inflammatory Disease

Proceedings of the National Academy of Sciences of the United States of America - United States
doi 10.1073/pnas.1106232108
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Proceedings of the National Academy of Sciences

Related search

CCAAT/Enhancer-binding Proteins

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
1999English

CCAAT/Enhancer-binding Protein Β Promotes Pathogenesis of EAE

Cytokine
BiochemistryAllergyImmunologyHematologyMolecular Biology
2017English

Inhibition of P90 Ribosomal S6 Kinase-Mediated CCAAT/Enhancer-binding Protein Β Activation and Cyclooxygenase-2 Expression by Salicylate

Journal of Biological Chemistry
BiochemistryCell BiologyMolecular Biology
2005English

Transcriptional Activation of the Mouse Obese (Ob) Gene by CCAAT/enhancer Binding Protein Alpha.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1996English

Avian Retroviral Long Terminal Repeats Bind CCAAT/enhancer-binding Protein.

Molecular and Cellular Biology
Cell BiologyMolecular Biology
1989English

Direct Binding of Toll-Like Receptor 2 to Zymosan, and Zymosan-Induced NF- B Activation and TNF- Secretion Are Down-Regulated by Lung Collectin Surfactant Protein A

Journal of Immunology
AllergyImmunology
2003English

CCAAT/enhancer-binding Protein Β: Its Role in Breast Cancer and Associations With Receptor Tyrosine Kinases

Expert Reviews in Molecular Medicine
Molecular MedicineMolecular Biology
2009English

CCAAT/Enhancer-binding Protein Homologous Protein (CHOP) Decreases Bone Formation and Causes Osteopenia

Bone
EndocrinologyPhysiologyHistologyMetabolismDiabetes
2007English

CCAAT/enhancer Binding Protein Deficiency Provides Cerebral Protection Following Excitotoxic Injury

Journal of Cell Science
Cell Biology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy